Clinical Trial Biorepository & Archiving Solutions Market (By Service: Archiving Solution, Biorepository Services; By Product: Preclinical, Clinical; By Phase: II, III) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Service Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Trial Biorepository & Archiving Solutions Market 

5.1. COVID-19 Landscape: Clinical Trial Biorepository & Archiving Solutions Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Trial Biorepository & Archiving Solutions Market, By Service

8.1. Clinical Trial Biorepository & Archiving Solutions Market, by Service, 2023-2032

8.1.1 Biorepository Services

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Archiving Solution Services

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Clinical Trial Biorepository & Archiving Solutions Market, By Product

9.1. Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2023-2032

9.1.1. Preclinical Products

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Clinical Products

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Clinical Trial Biorepository & Archiving Solutions Market, By Phase 

10.1. Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2023-2032

10.1.1. Phase I

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Phase II

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Phase III

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Phase IV

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Clinical Trial Biorepository & Archiving Solutions Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Service (2020-2032)

11.1.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.3. Market Revenue and Forecast, by Phase (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Phase (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Service (2020-2032)

11.2.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.3. Market Revenue and Forecast, by Phase (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Phase (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Service (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Phase (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Service (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Phase (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Service (2020-2032)

11.3.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.3. Market Revenue and Forecast, by Phase (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Phase (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Service (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Phase (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Service (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Phase (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Phase (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Service (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Phase (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Service (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Phase (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.3. Market Revenue and Forecast, by Phase (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Service (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Phase (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Service (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Phase (2020-2032)

Chapter 12. Company Profiles

12.1. Azenta U.S., Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Thermo Fisher Scientific Inc. (Patheon)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Precision for Medicine, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Medpace

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. LabCorp Drug Development

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ATCC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Q2 Solutions

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Labconnect

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Charles River Laboratories

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Cell&Co

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Frequently Asked Questions

The global clinical trial biorepository & archiving solutions market size was reached at USD 3.72 billion in 2022 and it is projected to hit around USD 8.3 billion by 2032.

The global clinical trial biorepository & archiving solutions market is growing at a compound annual growth rate (CAGR) of 8.36% from 2023 to 2032.

The North America region has accounted for the largest clinical trial biorepository & archiving solutions market share in 2022.

Report Details

  • Report Code:38472
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:March 2023
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers